Chronic Heart Failure Clinical Trial
Verified date | May 2018 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Physical activity is recommended in the treatment of heart failure. Elderly people demand
various forms of physical activity. Tai chi has shown to be an appreciated form of physical
activity among elderly, although there is a lack of studies focusing people aged 70 years and
older.
The overall goal with the project is to find a form of physical activity that is safe and
free from side effects, suitable for elderly people with chronic heart failure. The
hypothesis is that for patients participating in tai chi training during three months the
degree of self rated fatigue will be reduced and health-related quality of life will
increase, compared with a control group receiving ordinary care. The primary aim is to study
the effect of tai chi training on fatigue and health-related quality of life. A second aim is
to study effects on physical function and levels of brain natriuretic peptide (BNP) in blood
plasma. A tertiary aim is to describe the experience of participating in tai chi training.
A mixed methods study is conducted. Fortyfive patients with a verified diagnosis of heart
failure in the age of 70 years or older, who experience fatigue according to the Multi
Fatigue Inventory (MFI-20), was randomized to intervention or control group. Three groups
with 8-9 participants each completed a tai chi training programme twice-weekly for 16 weeks.
Data was collected at baseline, directly after the 16 weeks of training, and 6 and 12 months
thereafter. The programme is worked out by an expert in Chinese traditional medicine to suit
elderly people with chronic heart failure, and the classes were led by experienced leaders.
Before the start of the study a small pilot study was conducted to test the feasibility of
the programme. A group of seven patients completed the programme for eight weeks without any
problems.
If tai chi has a good effect on fatigue, health-related quality of life and physical
function, this form of physical activity can be a valuable complement to other medical
treatment. Tai chi has a potential to be offered to many patients to a relatively low cost.
It can be practiced in groups or in private, and also through internet connection.
Status | Completed |
Enrollment | 45 |
Est. completion date | May 2, 2018 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility |
Inclusion Criteria: - Verified diagnosis of heart failure - Left ventricle ejection fraction < 50 - Stable medical treatment with Angiotensin Converting Enzyme blockers and Betareceptor blockers (if no contraindications) experience of fatigue according to the Multidimensional Fatigue Inventory - 70 years or older - Swedish speaking Exclusion Criteria: - Instable angina pectoris - Myocardial infarction within the last three months - Cognitive impairment - No experienced fatigue |
Country | Name | City | State |
---|---|---|---|
Sweden | Umea University | Skelleftea | Vasterbotten |
Lead Sponsor | Collaborator |
---|---|
Umeå University | Stiftelsen Ronnbaret, The Swedish Heart and Lung Association, Visare Norr |
Sweden,
Barrow DE, Bedford A, Ives G, O´Toole LO, & Channer KS (2007). An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study. Postgrad Med, 83,717-721. Cheng TO (2007). Tai Chi: The Chinese ancient wisdom of an ideal exercise for cardiac patients. Int J Cardiol, 117, 293-295. (editorial) Dolansky MA, Moore SM, & Visovsky C (2006). Older adults´ views of cardiac rehabilitation programs. J Gerontol Nurs, 32(2), 37-44. Hägglund, L., Boman, K., Stenlund, H., Lundman, B., & Brulin, C. (2008). Factors related to fatigue among older patients with heart failure in primary health care. Int J Older People Nurs, 3(2), 96-103. Motivala SJ, Sollers J, Thayer J & Irwin MR (2006). Tai Chi Chih acutely decreases sympathetic nervous system activity in older adults. J Ger A Bio Sci Med, 61(11), 1177-1180. Rector TS, Kubo SH, & Cohn JN (1987). Patients´self-assessment of their congestive heart failure: Part 2: Content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Fail, 3, 198-209. Rees K, Taylor RS, Singh S, Coats AJS, & Ebrahim S (2004). Exercise based rehabilitation for heart failure. Cochrane Database of Systematic Reviews, (3) Art.No.: CD003331. DOI: 10.1002/14651858.CD003331.pub2. Smets EMA, Garssen B, Bonke B, de Haes JCJM. 1995. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res, 39 (5), 315-25. Verhagen AP, Immink M, van der Meulen A, & Bierma-Zeinstra SMA (2004). The efficacy of Tai Chi Chuan in older adults: a systematic review. Fam Pract, 21, 107-113. Yeh GY, Wood MJ, Lorell BH, Stevenson LW, Eisenberg DM, Wayne PM, Goldberger AL, Davis RB, & Phillips RS. (2004). Effects of Tai Chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: A randomized controlled trial. Am J Med, 117, 541-548.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | To describe the experience of participating in tai chi training | Qualitative individual interviews | after completed intervention | |
Primary | Changes from baseline values of the Multidimensional Fatigue Inventory, MFI-20 | A self-report instrument of five dimensions of fatigue. General fatigue, physical fatigue, mental fatigue, reduced activity and reduced motivation. | after intervention of 16 weeks, at 6 months and 12 months after intervention | |
Secondary | Changes from baseline values of the Minnesota Living With Heart Failure Questionnaire (LHFQ) | A self-report instrument aimed to measure the effects of symptoms, functional limitations and psychological distress on an individualĀ“s quality of life. | after intervention of 16 weeks, at 6 months and 12 months after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|